Northwestern Mutual Wealth Management’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
MIM
CCA
BFG
Northwestern Mutual Wealth Management's BBH Position: Q1 2026 in Review
Northwestern Mutual Wealth Management reduced its VanEck Biotech ETF (BBH) stake by 28% in Q1 2026, selling an estimated $62.6K and leaving 854 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #1995.
Northwestern Mutual Wealth Management first reported a position in BBH in Q2 2014 and has held it in 25 quarters since. The position peaked at $4.36M in Q3 2024. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- Northwestern Mutual Wealth Management held 854 shares of VanEck Biotech ETF worth $161K as of Q1 2026.
- Northwestern Mutual Wealth Management sold 325 VanEck Biotech ETF shares in Q1 2026, an estimated $62.6K.
- VanEck Biotech ETF made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #1995 holding.
- Northwestern Mutual Wealth Management first reported a position in VanEck Biotech ETF in Q2 2014 and has held it in 25 quarters since.
- Northwestern Mutual Wealth Management's VanEck Biotech ETF position peaked at $4.36M in Q3 2024.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.